ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,299 | -13.3% | 299,101 | +2.8% | 0.00% | – |
| Q2 2023 | $269,151 | -13.3% | 290,974 | +2.2% | 0.00% | – |
| Q1 2023 | $310,368 | -60.5% | 284,741 | -47.0% | 0.00% | – |
| Q4 2022 | $784,890 | +136.4% | 537,596 | +73.8% | 0.00% | – |
| Q3 2022 | $332,000 | -46.7% | 309,298 | -15.6% | 0.00% | – |
| Q2 2022 | $623,000 | -52.8% | 366,525 | -42.8% | 0.00% | – |
| Q1 2022 | $1,320,000 | -42.8% | 640,620 | +4.2% | 0.00% | – |
| Q4 2021 | $2,306,000 | -21.6% | 614,993 | +8.4% | 0.00% | – |
| Q3 2021 | $2,941,000 | +165.9% | 567,209 | +118.5% | 0.00% | – |
| Q2 2021 | $1,106,000 | -48.9% | 259,582 | -36.3% | 0.00% | – |
| Q1 2021 | $2,164,000 | +11.4% | 407,487 | +13.0% | 0.00% | – |
| Q4 2020 | $1,943,000 | +18.3% | 360,473 | +75.2% | 0.00% | – |
| Q3 2020 | $1,642,000 | -4.8% | 205,782 | +19.5% | 0.00% | – |
| Q2 2020 | $1,724,000 | +1012.3% | 172,231 | +348.1% | 0.00% | – |
| Q2 2019 | $155,000 | -8.8% | 38,434 | -2.6% | 0.00% | – |
| Q1 2019 | $170,000 | -27.4% | 39,453 | -2.9% | 0.00% | – |
| Q4 2018 | $234,000 | -52.4% | 40,623 | +12.0% | 0.00% | – |
| Q3 2018 | $492,000 | +14.2% | 36,273 | 0.0% | 0.00% | – |
| Q2 2018 | $431,000 | +1.7% | 36,273 | -3.9% | 0.00% | – |
| Q1 2018 | $424,000 | -37.5% | 37,753 | -62.8% | 0.00% | – |
| Q4 2017 | $678,000 | -19.0% | 101,379 | -0.8% | 0.00% | – |
| Q3 2017 | $837,000 | +183.7% | 102,200 | +55.3% | 0.00% | – |
| Q2 2017 | $295,000 | -18.7% | 65,800 | 0.0% | 0.00% | – |
| Q1 2017 | $363,000 | +36.5% | 65,800 | 0.0% | 0.00% | – |
| Q4 2016 | $266,000 | -42.7% | 65,800 | 0.0% | 0.00% | – |
| Q3 2016 | $464,000 | -13.4% | 65,800 | 0.0% | 0.00% | – |
| Q2 2016 | $536,000 | +0.2% | 65,800 | 0.0% | 0.00% | – |
| Q1 2016 | $535,000 | -32.6% | 65,800 | 0.0% | 0.00% | – |
| Q4 2015 | $794,000 | – | 65,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |